跳至主要内容
临床试验/NCT00219440
NCT00219440已完成4 期

A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS

Pennington Biomedical Research Center2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2003年2月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
2
主要终点
glucose

研究概览

简要总结

We hypothesized that a portion controlled diet would prevent the weight gain associated with the use of a peroxisome profliferator-activated receptor-gamma (PPAR-g). This is a 4 months randomized clinical trial in type 2 diabetics who are treated with pioglitazone and a standard diet, pioglitazone and a portion-controlled diet and metformin with a standard diet.

详细描述

A total of 60 male and female type 2 diabetic subjects will be recruited and randomized into 1 of 3 treatment groups for the 4 months long trial

  1. ACTOS plus a standard diet
  2. ACTOS plus a portion-controlled diet
  3. Metformin plus a standard diet. The end-point of the trial is the change in body fat content from baseline to the end of the trial

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women age 35 to 75 who have type 2 diabetes mellitus

排除标准

  • Individuals with co-existing other diseases

结局指标

主要结局

glucose

时间窗: 4 months

次要结局

  • Change in lipids(4 months)
  • blood pressure(4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

George A. Bray

Professor, Adjunct

Pennington Biomedical Research Center

研究点 (2)

Loading locations...

相似试验